Home > Boards > US Listed > Biotechs > HEAT BIOLOGICS INC (HTBX)

The Chinese are coming::::: URHAM, NC / ACCESSWIRE

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Paraceratherium Member Profile
 
Followed By 0
Posts 230
Boards Moderated 0
Alias Born 06/29/17
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/24/2019 6:07:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/21/2019 5:21:37 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 6/4/2019 5:02:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2019 2:41:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2019 7:32:36 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 5/22/2019 4:53:03 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 7:52:28 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2019 7:46:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2019 9:02:10 AM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/24/2019 5:09:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/18/2019 5:06:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/18/2019 5:01:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/4/2019 6:02:57 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 4/4/2019 6:02:22 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/2/2019 8:17:11 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/28/2019 7:48:23 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/28/2019 7:36:45 AM
Amended Securities Registration (section 12(b)) (8-a12b/a) Edgar (US Regulatory) - 3/13/2019 6:08:07 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/12/2019 8:01:46 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/28/2019 5:53:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/28/2019 2:39:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/25/2019 5:05:10 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 2:21:49 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 1:43:46 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/14/2019 4:32:38 PM
Paraceratherium   Tuesday, 03/05/19 09:41:42 AM
Re: None
Post # of 2985 
The Chinese are coming::::: URHAM, NC / ACCESSWIRE / March 5, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing "off-the-shelf" T-cell therapies designed to activate a patient's immune system against cancer, today announced that John Prendergast, Heat Biologic's Lead Board member, will chair a roundtable discussion at 4:00-5:00 pm China Standard Time (CST), on Wednesday, March 6, 2019 at the WuXi Healthcare Forum at the St. Regis Shanghai Jingan Hotel. The Forum brings together more than 5,000 industry leaders from 2,000 organizations spanning 20 countries to share their collective insights on the global challenges facing healthcare and future possibilities.

Dr. Prendergast will chair a panel on oncology, which will focus on promising new developments in the space.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist